Thu 13 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
2014-07-07
Risk of hypersensitivity reactions of products containing ambroxol and bromhexine
The Saudi Food and Drug Authority would like to inform the healthcare professionals and the public that after reviewing the safety profile for...
2013-02-26
Drug Sector Welcomes Al Majma’ah University Students
SFDA welcomed at its Head Office a student delegation from the faculty of Medicine & Pharmacology of Al Majma’ah University, on Tuesday 2/4/1434H. The...
2013-02-11
Saudi Food and Drug Authority (SFDA) PRESS RELEASE- Safety of Diane 35® and Risk of Thromboembolism
The Saudi Food and Drug Authority (SFDA) would like to share some recent information regarding use of Diane 35® (cyproterone acetate 2 mg + ethinyl...
2013-02-10
Measures to minimise the risk of developing nephrogenic systemic fibrosis with the use of gadolinium-containing contrast agents
The European Committee for Medicinal Products for Human Use (CHMP) has reviewed the risk of nephrogenic systemic fibrosis (NSF) with gadolinium...
2013-02-10
Rare Cases of Liver Injury Reported with Use of Orlistat (Xenical®)
Orlistat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) ≥ 30 kg/m2 and...
2013-02-10
Safety Warning of accidental overdose reported in infants and children with intravenous paracetamol (Perflgan®)
Dear Healthcare Provider : Saudi Food and Drug Authority would like to draw the attention of healthcare professionals to the risk of accidental...Last update date: 13/08/2026 at 12:55 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.